注册一亩三分地论坛,查看更多干货!
您需要 登录 才可以下载或查看附件。没有帐号?注册账号
x
AI for biomedical research
以往实验室的每个成员都有至少一篇一作或者共同一作的论文(Nature, Nature Biotechnology, Clinical Cancer Research, Nature communications),并找到faculty的职位 或者在世界顶尖医药研发企业 Genentech, Bristol Myers Squibb从事生物信息的工作。
这个PhD学生的培养以机器学习和大模型为主,只是应用到生物医学领域。
目前实验室的主要研究方向:
1. 单细胞分析算法 (Nature Biotechnology 2022; Nature Machine Intelligence 2023)
2. 临床癌症免疫治疗测序 (Nature 2022)
3. 临床肿瘤抗药性测序数据分析(Clinical Cancer Research 2020, 2021; PNAS 2020)
4. 医学大数据挖掘 (Nature Communications 2021, 2022)
About OHSU
OHSU is ranked as one of the nation’s top 30 medical schools. With long-term resource commitments, such as the $1 billion Knight cancer “challenge”, substantial resource is provided to support state-of-the-art computational research, including a world-class exascale supercomputing cluster, close interactions and resource commitments by leading technology companies such as Intel, tight integration with clinical and basic research programs across campus. OHSU Knight Cancer Institute, directed by Dr. Brian Druker, is an NCI comprehensive cancer center and is named after Nike co-founder Phil Knight.
We are looking for:
• A lab member with a passion for applying AI in biomedicine.
• Familiar with deep learning models including RNN, GCN, Transformer, etc.
• Experience in machine learning and transfer learning is highly valued.
欢迎对医学大数据分析感兴趣的同学联系实验室PI: Zheng Xia |